Annual meeting of ISRTP, the ISRTPCON 2026 will be held at St Johns Medical College, Bengaluru from 12-14th November 2026.
For details and registration, please visit https://t.co/HbKjmJSkzz
Sorry I accidentally deleted the original post while trying to answer some questions.
I’m still a novice with X 😁
Take home message: small ~3% of PLA2R negative MN cases by routine IF are PLA2R positive by LMD/MS.
https://t.co/070fDPcLbM
Key insight: Anti-nephrin podocytopathy is a low-titer autoantibody disease. Enrichment steps to capture circulating antibodies facilitate the robust quantification of disease activity. @NicolaMTomas@hengel_f@AstridWeins
Announcing the 2nd edition of annual ISRTP post graduate outreach program (iPROP2). Great opportunity for Pathology and Nephrology fellows and consultants to brush up your skills https://t.co/09gvlVZne1
#iprop#renalpathology#nephrology
MAGI2, is a new biomarker for glomerulopathies! 🌟 This slit diaphragm protein is key to nephrin 🐙localization and causes effacement shown with our rapid zebrafish model. 🐟🔬
With MAGI2, we can distinguish primary from secondary FSGS!
As shown in our manuscript uploaded at bioRxiv, even FSD (filtration slit density) measured by PEMP at @NIPOKA_Podocyte alone offers a clear differentiation between primary and secondary FSGS, marking an amazing step for kidney biopsy analysis and patient care!
This discovery is a result of extraordinary collaboration within the STOP-FSGS project, funded by BMBF, bringing together world-class research teams:
🇩🇪 @Tobias_B_Huber 's lab
🇩🇪 UKE Pathology
🇫🇷 Christos Chatziantoniou's lab
🇮🇹 @GianniCapasso4 's lab
🇩🇪 Thomas Benzing ’s lab
🇩🇪 Uwe Völker's lab
🇩🇪 @NIPOKA_Podocyte GmbH
🇩🇪 and my fantastic team at the @UMGreifswald
https://t.co/9embf4mr5O
A heartfelt thank you to all involved in this international effort !🌍💪🔬🙏
We have migrated to a brand new website! Please access the new website of Indian Society of Renal & Transplantation Pathology at https://t.co/09gvlVZne1 for recent updates about our activities, academic content and much more.#newwebsite#renalpathology#PathTwitter
This is difficult & rare.
Suspicion is key.
LM-large glomeruli, appear hypercellular, but a closer look & you see foam cells.
Stain for CD68 & glomerular capillaries light up & are filled with CD68+ macrophages.
IF/EM essentially negative.
Dx: Histiocytic glomerulopathy
1/3
Donor-derived cell-free DNA monitoring for early diagnosis of antibody-mediated rejection after kidney transplantation
https://t.co/Ihj59qVsjF
Dd-cfDNA-guided biopsy in KTR with prevalent dnDSA can reduce the time to AMR diagnosis and expedite therapy initiation
Monotypic fibrillary glomerulonephritis is not a MGRS in the vast majority of cases.
In cases with monotypic fibrillary - do IgG subclasses, do par IF, and check SPEP/UPEP for evaluation of true clonality.
Insights from @VBijol and @MayoClinicPath at @GlomCon
Kidney-transplant microvascular inflammation has a varied clinical presentation. This study of more than 16,000 biopsy specimens supports the recognition of additional rejection phenotypes to standardize diagnostics. https://t.co/FzWH6RAY28
#KidneyWk
AIIMS, Delhi & Mayo Clinic are getting together to talk about the latest advances in Kidney diseases and Transplant. An interesting program with a look at the latest in Complement, Genetics, Stem cell therapy with a plethora of real life cases. Join us @isn_india@IndianRenal
Membranous Nephropathy (MN): It is becoming increasingly important to identify the antigen in MN.
Each MN-antigen has distinctive clinical, pathology, and prognostic implications.
Mass spectrometry is the method of choice for identifying MN antigens.
https://t.co/xp3vDOOwET